Page last updated: 2024-12-05

cyclohexane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyclohexane: C6H12 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclohexane : An alicyclic hydrocarbon comprising a ring of six carbon atoms; the cyclic form of hexane, used as a raw material in the manufacture of nylon. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8078
CHEMBL ID15980
CHEBI ID29005
MeSH IDM0005468

Synonyms (96)

Synonym
CHEBI:29005 ,
hexahydro-benzene
ai3-08222
un1145
hsdb 60
einecs 203-806-2
caswell no. 269
cykloheksan [polish]
cicloesano [italian]
rcra waste no. u056
epa pesticide chemical code 025901
cyclohexaan [dutch]
cyclohexan [german]
benzenehexahydride
nsc 406835
ccris 3928
rcra waste number u056
cyclohexane, puriss., >=99.5% (gc)
inchi=1/c6h12/c1-2-4-6-5-3-1/h1-6h
hexahydrobenzene
benzene, hexahydro-
hexanaphthene
cykloheksan
cicloesano
cyclohexan
nsc406835
nsc-406835
wln: l6tj
cyclohexaan
hexamethylene
110-82-7
cyclohexane
GHL.PD_MITSCHER_LEG0.242
cyclohexane, acs spectrophotometric grade, >=99%
68411-76-7
cyclohexane, anhydrous, 99.5%
zyklohexan
BMSE000545
CHEMBL15980
AKOS000119975
NCGC00248918-01
cas-110-82-7
dtxsid4021923 ,
dtxcid701923
NCGC00258639-01
tox21_201087
68512-15-2
STL283116
cyclohexane [un1145] [flammable liquid]
48k5mkg32s ,
ciclohexano
ec 203-806-2
unii-48k5mkg32s
FT-0624180
FT-0624182
cyclohexane [mart.]
cyclohexane [fcc]
cyclohexane [usp-rs]
cyclohexane [mi]
cyclohexane [hsdb]
cyclohexane [inci]
un 1145
cylohexane
cyclo-hexane
cylcohexane
mfcd00003814
cyclohexane, hplc grade
cyclohexane hplc grade
cyclohexane, laboratory reagent, >=99.8%
benzene hexahydride
cyclohexane, >=99.5%, pra grade
cyclohexane, saj first grade, >=99.0%
cyclohexane, hplc grade, >=99.9%
cyclohexane, for hplc, >=99.9%
cyclohexane, puriss. p.a., acs reagent, >=99.5% (gc)
cyclohexane, for hplc
cyclohexane, jis special grade
cyclohexane, acs reagent, >=99%
cyclohexane, for hplc, >=99.7%
cyclohexane, analytical standard
cyclohexane, uv hplc spectroscopic, 99.5%
cyclohexane, pharmaceutical secondary standard; certified reference material
cyclohexane, p.a., 99.0%
cyclohexane, p.a., acs reagent, 99.0%
cyclohexane, hplc uv/ir isocratic grade, min. 99.9%
cyclohexane, ar, >=99.5%
cyclohexane, lr, >=99%
cyclohexane 2000 microg/ml in methanol
12217-02-6
cyclohexane, acs grade
BCP08072
Q211433
AMY11047
acid red 300
cyclohexane (mart.)
astm method d5191 vapor pressure - 22.5 kpa (3.26 psi)

Research Excerpts

Overview

Cyclohexane (CHX) is an organic solvent commonly used as a drug-of-abuse. It has been utilized as a safe substitute of several organic solvents in diverse industrial processes, such as adhesives, paints, paint thinners, fingernail polish and lacquers.

ExcerptReferenceRelevance
"Cyclohexane is a representative of volatile organic compounds (VOCs). "( Evaluation of HKUST-1 as Volatile Organic Compound Adsorbents for Respiratory Filters.
Cardenas, C; Collomb, C; Daniel, C; Díaz, E; Farrusseng, D; Ordóñez, S; Ursueguía, D, 2022
)
2.16
"Cyclohexane (CHX) is an organic solvent commonly used as a drug-of-abuse. "( Cyclohexane Inhalation Produces Long-Lasting Alterations in the Hippocampal Integrity and Reward-Seeking Behavior in the Adult Mouse.
Buritica, J; Campos-Ordonez, T; Gonzalez-Perez, O; Ibarra-Castaneda, N; Zarate-Lopez, D, 2019
)
3.4
"Cyclohexane is a volatile substance that has been utilized as a safe substitute of several organic solvents in diverse industrial processes, such as adhesives, paints, paint thinners, fingernail polish, lacquers, and rubber industry. "( Cyclohexane produces behavioral deficits associated with astrogliosis and microglial reactivity in the adult hippocampus mouse brain.
Campos-Ordonez, T; Galvez-Contreras, AY; Gonzalez-Perez, O; Guzman-Muniz, J; Moy-Lopez, N; Zarate-Lopez, D, 2015
)
3.3
"Cyclohexane is a recalcitrant compound that is more difficult to degrade than even n-alkanes or monoaromatic hydrocarbons. "( Characterization of cyclohexane and hexane degradation by Rhodococcus sp. EC1.
Cho, KS; Lee, EH, 2008
)
2.11

Toxicity

ExcerptReferenceRelevance
" Several PEs, however, were found to have adverse effects on the health of animals."( Evaluation of the 52-week chronic toxicity of a novel phthalate-free plasticizer, Eco-DEHCH (bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate), in Han Wistar rats.
Cha, HJ; Han, HJ; Jeong, DS; Kang, J; Ko, SM; Lee, DH; Lee, JY; Son, WC, 2023
)
1.12

Pharmacokinetics

ExcerptReferenceRelevance
"This report describes a physiologically based pharmacokinetic model for cyclohexane and its use in comparing internal doses in rats and volunteers following inhalation exposures."( Physiologically based pharmacokinetic modeling of cyclohexane as a tool for integrating animal and human test data.
Freidig, AP; Hissink, AM; Kruse, J; Kulig, BM; Lammers, JH; McKee, RH; Muijser, H; Owen, DE; Salmon, F; Sweeney, LM; Verwei, M,
)
0.62
" The pharmacodynamic effect of the chosen preparation was tested on the shaved back of histamine sensitized rabbits."( Microencapsulation of hydroxyzine HCl by thermal phase separation: in vitro release enhancement and in vivo pharmacodynamic evaluation.
Ibrahim Soliman, I; latif Aziz, R; Zaki Rizkalla, CM, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
"In this study, chitosan-zinc oxide nanoparticles were used as a sorbent of miniaturized matrix solid-phase dispersion combined with flotation-assisted dispersive liquid-liquid microextraction for the simultaneous determination of 13 n-alkanes such as C8 H18 and C20 H42 in soil samples."( Matrix solid-phase dispersion with chitosan-zinc oxide nanoparticles combined with flotation-assisted dispersive liquid-liquid microextraction for the determination of 13 n-alkanes in soil samples.
Arefnejad, E; Bohlooli, M; Khajeh, M; Yan, H, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
" The objectives of this study was aimed to determine the correlation among bioavailability of petroleum hydrocarbons, SOM content, and DOM level in soil-water systems."( Effects of natural organic matters on bioavailability of petroleum hydrocarbons in soil-water environments.
Chen, CH; Liu, PG; Whang, LM, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
non-polar solventnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cycloalkaneSaturated monocyclic hydrocarbons (with or without side chains).
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency15.81080.006038.004119,952.5996AID1159521; AID1159523
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency55.98200.000657.913322,387.1992AID1259377
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency2.80570.003041.611522,387.1992AID1159555
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency8.87260.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1676780Induction of membrane perturbation in DC22:1PC LUV bilayer assessed as fluorescence quench rate by measuring gramicidin mixture monomer to dimer equilibrium at 30000 uM by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID532773Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant in presence of IPTG and chlorpromzine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1676773Induction of membrane perturbation in DC22:1PC LUV bilayer assessed as effect on potential of mean force by measuring increase in deltaG for gramicidin mixture monomer to dimer and pure gramicidin-bilayer by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID603952In-vitro blood to lung partition coefficients of the compound, logP(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID532770Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID532767Antimicrobial activity against Salmonella serovar Typhimurium SL13442008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID416913Convulsant activity in Sprague-Dawley rat assessed as partial pressure in atmosphere at which convulsion takes place2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Prediction of convulsant activity of gases and vapors.
AID532768Antimicrobial activity against Salmonella serovar Typhimurium SL1344 in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1676781Induction of membrane perturbation in DC20:1PC LUV bilayer assessed as fluorescence quench rate by measuring gramicidin mixture monomer to dimer equilibrium at 30000 uM by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID532771Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID532769Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1676783Induction of membrane perturbation in DC18:1PC LUV bilayer assessed as fluorescence quench rate by measuring gramicidin mixture monomer to dimer equilibrium at 30000 uM by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID1676771Induction of membrane perturbation in DC18:1PC LUV bilayer assessed as effect on potential of mean force by measuring increase in deltaG for gramicidin mixture monomer to dimer and pure gramicidin-bilayer by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID603950In-vitro air to lung partition coefficients of the compound, logK(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1676778Induction of membrane perturbation in DC22:1PC LUV bilayer assessed as fluorescence quench rate by measuring reduction in R(drug)/R(control) ratio by fluorescence quenching assay2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID646176Inverse agonist activity at human red cone opsin expressed in COS1 cells assessed as transducer activity at 2 mM by radioactive filter binding assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Probing human red cone opsin activity with retinal analogues.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID603951In-vitro air to blood partition coefficients of the compound, logK(blood) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID532772Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant in presence of IPTG2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1676776Induction of membrane perturbation in DC22:1PC LUV bilayer assessed as change in deltaG for gramicidin mixture monomer to to dimer by fluorescence quenching assay (Rvb = 0 kcal/mol)2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
AID1676775Induction of membrane perturbation in DC22:1PC LUV bilayer assessed as change in deltaG for pure gramicidin monomer to to dimer by fluorescence quenching assay (Rvb = 0 kcal/mol)2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (705)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990159 (22.55)18.7374
1990's0 (0.00)18.2507
2000's164 (23.26)29.6817
2010's344 (48.79)24.3611
2020's38 (5.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.67 (24.57)
Research Supply Index6.59 (2.92)
Research Growth Index6.91 (4.65)
Search Engine Demand Index155.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (88.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (1.24%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other718 (98.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]